Sign In
Buy CLF
$14.43
+0.280 (+1.98%)
At Close: Jun 04, 2026
Cleveland-Cliffs: Could Be Getting Better
12:39pm, Friday, 25'th Nov 2022
The steel sector is showing some tentative promise of having found a bottom. In the past month, we've seen ample rumors that China's real estate market might be staging a comeback, as the government p
Cleveland-Cliffs (CLF) Up 7.7% Since Last Earnings Report: Can It Continue?
04:31pm, Thursday, 24'th Nov 2022 Zacks Investment Research
Cleveland-Cliffs (CLF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Final Trades: Cleveland-Cliffs, Stanley Black & Decker, GM & more
09:19am, Saturday, 19'th Nov 2022
The "Halftime Report" traders give their top picks to watch for the second half.
Why Invest In This European Bank? Jim Cramer Says 'We've Got So Many Good Banks In Our Country'
01:26pm, Wednesday, 16'th Nov 2022 Benzinga
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Amerco (NASDAQ: UHAL) is an "inexpensive stock. " He added, "I think it might be a good place to be. I’ll do more work on it."
When asked ab
Don't Worry, Cleveland-Cliffs Should Bounce Back in Q4
02:32pm, Thursday, 03'rd Nov 2022 The Motley Fool
The domestic steelmaker had a particularly bad third quarter, but management believes the fourth quarter will be better.
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022
02:06pm, Wednesday, 02'nd Nov 2022 Benzinga
Upgrades
According to Evercore ISI Group, the prior rating for BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) was changed from In-Line to Outperform. In the third quarter, BioCryst Pharmaceuticals showed
Is WisdomTree U.S. MidCap ETF (EZM) a Strong ETF Right Now?
10:20am, Monday, 31'st Oct 2022 Zacks Investment Research
Smart Beta ETF report for EZM
Steel Companies' Profits Hurt by Falling Prices
10:00am, Sunday, 30'th Oct 2022
Cleveland-Cliffs, United States Steel, Nucor and Steel Dynamics reported significantly lower profits from their steelmaking operations during the quarter that wrapped up at the end of September, compa
Cramer Says Stay With This Stock As It Is 'Really, Really Well-Run Company'
12:06pm, Friday, 28'th Oct 2022 Benzinga
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended staying with Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), and added that it’s a "really, really well-run company."
When asked a
What 5 Analyst Ratings Have To Say About Cleveland-Cliffs
02:17pm, Wednesday, 26'th Oct 2022 Benzinga
Cleveland-Cliffs (NYSE:CLF) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
3
1
1
0
0
Last 30
Cleveland-Cliffs (CLF) Misses Q3 Earnings and Revenue Estimates
12:18pm, Wednesday, 26'th Oct 2022 Zacks Investment Research
Cleveland-Cliffs (CLF) witnessed higher steelmaking unit costs on a sequential comparison basis in the third quarter.
Cleveland-Cliffs (CLF) Misses Q3 Earnings and Revenue Estimates
09:47am, Wednesday, 26'th Oct 2022
Cleveland-Cliffs (CLF) witnessed higher steelmaking unit costs on a sequential comparison basis in the third quarter.
TrueBlue, Xerox, Brown & Brown And Other Big Losers From Tuesday
09:01am, Wednesday, 26'th Oct 2022 Benzinga
U.S. stocks closed higher on Tuesday, with the Dow Jones gaining over 300 points. Here is the list of some big stocks recording losses in the previous session.
Crown Holdings, Inc. (NYSE: CCK) share
Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday
08:29am, Wednesday, 26'th Oct 2022 Benzinga
Gainers
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) surged 97.4% to close at $2.98 after Astellas Pharma Inc announced it will invest a total of $50 million to acquire 15% of the company.
Fangdd Netwo
Cleveland-Cliffs (CLF) Q3 2022 Earnings Call Transcript
06:30pm, Tuesday, 25'th Oct 2022 The Motley Fool
CLF earnings call for the period ending September 30, 2022.
